US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Organon & Co. Common Stock
(NY:
OGN
)
13.72
+0.01 (+0.07%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co. Common Stock
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
FDA surprise
↗
June 07, 2021
The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year.
Via
Talk Markets
Merck Completes Women's Health Organon Spinoff
↗
June 03, 2021
In a move to free up a cash windfall and streamline the business, Merck & Co Inc (NYSE: MRK) had long planned to slice away its women’s health business into a...
Via
Benzinga
ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company
June 03, 2021
From
Organon
Via
Business Wire
Inside Merck's Organon Spinoff And Why It Could Be Worth Billions
↗
June 03, 2021
Don't think of Merck spinoff Organon as a research engine. The new pharmaceutical stock — which begins active trading on Thursday — is a commercial entity.
Via
Investor's Business Daily
Organon Launches as New Global Women’s Health Company
June 03, 2021
From
Organon & Co.
Via
Business Wire
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >